[Federal Register Volume 67, Number 33 (Tuesday, February 19, 2002)]
[Notices]
[Pages 7391-7392]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-3832]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2, notice is hereby giving of a meeting of 
the Secretary's Advisory Committee on Xenotransplantation.
    The meeting will be open to the public; however, seating is limited 
and pre-registration is encouraged. To pre-register, please contact 
Capital Consulting Corporation (Joanne Mowczko) at 301-468-6001, ext. 
418. Individuals who plan to attend and need special assistance, such 
as sign language interpretation or reasonable accommodations, should 
notify Ms. Mowczko is advance of the meeting.
    Name of Committee: Secretary's Advisory Committee on 
Xenotransplantation.
    Date: March 11-12, 2002.
    Time: March 11--8:00 am to 5:00 PM. March 12--8:00 am to 
adjournment.
    Agenda: The SACX will focus on a variety of issues relating to the 
science of xenotransplantation and to informed consent issues in 
xenotransplantation clinical trials. The first day of the SACX meeting 
will include presentations and discussions of endothelial cell-host 
interactions in solid organ xenotransplantation; transgenic and cloning 
technologies; cellular transplants; extracorporeal technologies; 
complement and coagulation systems; and immune rejection and tolerance. 
The second day will include concurrent breakout sessions during which 
the SACX Working Groups will convene, and plenary discussion of their 
progress. Closer to the meeting, a more updated agenda will be 
available electronically at http://www4.od.nih.gov/oba/Sacx.htm
    Public Comment: Individuals who wish to provide public comment 
(oral or written) should contact the SACX Executive Director, Mary 
Groesch, by telephone at 301-496-0785, or email at [email protected].
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Mary Groesch, Ph.D., Executive Director, 
Secretary's Advisory Committee on Xenotransplantation, Office of 
Science Policy, Rockledge, I, Room 750, Bethesda MD 20892, 301-496-9838

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research

[[Page 7392]]

Training Award; 93.187, Undergraduate Scholarship Program for 
Individuals from Disadvantaged Backgrounds; 93.22, Clinical Research 
Loan Repayment Program for Individuals from Disadvantaged 
Backgrounds; 93.232, Loan Repayment Program for Research Generally; 
93.39, Academic Research Enhancement Award; 93.936 yNIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program, National 
Institutes of Health HHS)

    Dated: February 07, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-3832 Filed 2-15-02; 8:45 am]
BILLING CODE 4140-01-M